BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND KCNJ5, ENSG00000120457, 3762, P48544, KIR3_4, KATP1, GIRK4 AND Diagnosis
24 results:

  • 1. Thyroid cancer patient reported outcome measures in clinical practice: analysing acceptability and optimizing recruitment.
    O'Neill CJ; Morris-Baguley H; Alam AS; Carlson MA; Blefari N; Rowe CW; Fradgley EA; Paul C
    ANZ J Surg; 2023 Sep; 93(9):2214-2221. PubMed ID: 37391881
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary aldosteronism caused by a pI157S somatic
    Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
    Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
    Nanba K; Baker JE; Blinder AR; Bick NR; Liu CJ; Lim JS; Wachtel H; Cohen DL; Williams TA; Reincke M; Lyden ML; Bancos I; Young WF; Else T; Giordano TJ; Udager AM; Rainey WE
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2473-2482. PubMed ID: 35779252
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical characteristics and genetic analyses in a Chinese family affected by primary aldosteronism: a case report.
    Li J; Zhao J; He W; Yuan G
    Ann Palliat Med; 2021 Jul; 10(7):8378-8383. PubMed ID: 33894703
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature.
    Zhang Y; Tan J; Yang Q; Du Z; Yang S; He W; Song Y; Hu J; Yang Y; Li Q; Zhang Y; He Y; Cheng Q;
    J Med Case Rep; 2020 Feb; 14(1):32. PubMed ID: 32075693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. kcnj5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
    Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomics of benign adrenocortical tumors.
    Jouinot A; Armignacco R; AssiƩ G
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105414. PubMed ID: 31207362
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Macrolides for kcnj5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Macrolides selectively inhibit mutant kcnj5 potassium channels that cause aldosterone-producing adenoma.
    Scholl UI; Abriola L; Zhang C; Reimer EN; Plummer M; Kazmierczak BI; Zhang J; Hoyer D; Merkel JS; Wang W; Lifton RP
    J Clin Invest; 2017 Jun; 127(7):2739-2750. PubMed ID: 28604387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
    Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
    Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aldosterone-Producing Adenoma With a Somatic kcnj5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
    Vouillarmet J; Fernandes-Rosa F; Graeppi-Dulac J; Lantelme P; Decaussin-Petrucci M; Thivolet C; Peix JL; Boulkroun S; Clauser E; Zennaro MC
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3874-3878. PubMed ID: 27648962
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Double adrenocortical adenomas harboring independent kcnj5 and PRKACA somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic disorders in primary aldosteronism-familial and somatic.
    Funder JW
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):154-157. PubMed ID: 27013018
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
    Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
    PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
    Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
    Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Functional histopathological markers of aldosterone producing adenoma and somatic kcnj5 mutations.
    Fernandes-Rosa FL; Amar L; Tissier F; Bertherat J; Meatchi T; Zennaro MC; Boulkroun S
    Mol Cell Endocrinol; 2015 Jun; 408():220-6. PubMed ID: 25617716
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An update on novel mechanisms of primary aldosteronism.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A novel kcnj5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. kcnj5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
    J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.